The National Center for Cannabis Research and Education at the University of Mississippi is partnering with Southern Sky Brands on a clinical study examining how cannabidiol (CBD) affects sleep among adults.
Researchers will evaluate several sleep-related outcomes, including sleep duration, overall sleep quality and participant-reported measures of wellness.
The National Center for Cannabis Research and Education (NCCRE) said the research is intended to generate stronger scientific evidence regarding the potential use of cannabinoid-based products for sleep-related concerns.
“This collaboration reflects our shared commitment to generating high-quality scientific data that can help patients, healthcare professionals, and policymakers better understand the potential benefits of cannabinoids,” said NCCRE Director Robert Welch.
Southern Sky Brands is a Mississippi-based medical marijuana company that cultivates and processes products for the state’s medical marijuana program.
“We are proud to partner with one of the nation’s leading cannabis research institutions to further investigate CBD’s potential role in supporting sleep and overall wellness,” said Charles Thompson, the company’s director of operations. “As a Mississippi company, we believe investing in clinical research is essential to advancing patient care and building trust through science.”
According to the announcement, the study will examine both the safety and effectiveness of CBD-based interventions. Researchers said the findings could support future studies and help patients, healthcare professionals and policymakers make evidence-based decisions regarding medical marijuana.
The organizations did not announce the planned number of participants, the CBD dosage or formulation that will be used, whether the study will include a placebo group or when the research is expected to begin.
Additional information regarding participant enrollment, the study timeline and eventual results will be released later, according to the announcement.
